BACKGROUND. The use of adjuvant chemotherapy to treat adults with localized resectable
soft‐tissue sarcoma remains controversial. The objective of this systematic review was to …

Uterine leiomyosarcoma is the most common type of uterine sarcoma. It is an extremely
aggressive malignancy associated with a poor overall prognosis. Women affected may vary …

Highlights•This Clinical Practice Guideline provides key recommendations on the
management of soft tissue and visceral sarcomas.•Recommendations have been agreed …

Soft tissue sarcomas (STSs) gather over 80 histological entities, with even more molecular
subsets, characterised by a low to very low incidence in all populations. The majority of …

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis …

Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a
heterogenous mix of clinical and pathologic characteristics. STS can develop from fat …

Background Effective targeted treatment is unavailable for most sarcomas and doxorubicin
and ifosfamide—which have been used to treat soft-tissue sarcoma for more than 30 years …

Background To determine efficacy and safety of bevacizumab, a recombinant humanized
antibody against vascular endothelial growth factor (VEGF), in the treatment of metastatic or …

Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a
heterogenous mix of clinical and pathologic characteristics. STS can develop from fat …

Purpose To update the 2000 American Society of Clinical Oncology guideline on the use of
hematopoietic colony-stimulating factors (CSF). Update Methodology The Update …